Regulation of parasite antigen-driven immune responses by interleukin-10 (IL-10) and IL-12 in lymphatic filariasis

被引:85
作者
Mahanty, S
Ravichandran, M
Raman, U
Jayaraman, K
Kumaraswami, V
Nutman, TB
机构
[1] NIAID, LPD, HELMUNTH IMMUNOL SECT, NIH, BETHESDA, MD 20892 USA
[2] ICMR, TB RES CTR, MADRAS, TAMIL NADU, INDIA
关键词
D O I
10.1128/IAI.65.5.1742-1747.1997
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We investigated the mechanisms by which interleukin-10 (IL-10) regulates antigen-specific haporesponsiveness in asymptomatic microfilaremic (MF) individuals. Peripheral blood mononuclear cells from MF individuals (n = 11) were stimulated in vitro with Brugia malayi antigen (BMA) or mycobacterial purified protein derivative (PPD) in the presence of neutralizing anti-IL-10 or isotype control monoclonal antibodies. As expected, BMA stimulated little or no gamma interferon (IFN-gamma) secretion in MF individuals, whereas PPD stimulated IFN-gamma in all but one. Neutralization of endogenous BMA-driven IL-10 secretion led to augmentation of IFN-gamma in seven of nine RIF individuals (1.5- to 10-fold) and did so in a BMA-specific manner (PPD-driven IFN-gamma was augmented in only two of eight MF individuals and only 1.5- to 2-fold), indicating that IL-10 downregulates type 1 responses in these individuals. Type 2 responses (IL-5 secretion) were unaffected by the IL-10 blockade, To assess whether IL-12 could reverse the type 1 downregulation observed, the effect of recombinant human IL-12 (rhIL-12) on BMA-driven IL-5 and IFN-gamma production was also evaluated, rhIL-12 augmented both BMA- and PPD-driven IFN-gamma production 5- to 10-fold in six of nine MF individuals. These data demonstrate that IL-10 downregulates BMA-driven type 1 responses and that IL-12 can overcome downregulation of Th1 responses associated with MF but does so in a non-antigen-specific manner.
引用
收藏
页码:1742 / 1747
页数:6
相关论文
共 52 条
[1]   STRATEGIES OF ANTICYTOKINE MONOCLONAL-ANTIBODY DEVELOPMENT - IMMUNOASSAY OF IL-10 AND IL-5 IN CLINICAL-SAMPLES [J].
ABRAMS, JS ;
RONCAROLO, MG ;
YSSEL, H ;
ANDERSSON, U ;
GLEICH, GJ ;
SILVER, JE .
IMMUNOLOGICAL REVIEWS, 1992, 127 :5-24
[2]   CD1 RECOGNITION BY MOUSE NK1(+) T-LYMPHOCYTES [J].
BENDELAC, A ;
LANTZ, O ;
QUIMBY, ME ;
YEWDELL, JW ;
BENNINK, JR ;
BRUTKIEWICZ, RR .
SCIENCE, 1995, 268 (5212) :863-865
[3]   EFFECTS OF IL-12 ON IMMUNE-RESPONSES TO MICROBIAL INFECTIONS - A KEY MEDIATOR IN REGULATING DISEASE OUTCOME [J].
BIRON, CA ;
GAZZINELLI, RT .
CURRENT OPINION IN IMMUNOLOGY, 1995, 7 (04) :485-496
[4]   MACROPHAGE DEACTIVATION BY INTERLEUKIN-10 [J].
BOGDAN, C ;
VODOVOTZ, Y ;
NATHAN, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (06) :1549-1555
[5]  
CESANO A, 1993, J IMMUNOL, V151, P2943
[6]   INTERLEUKIN-10 (IL-10) INHIBITS THE INDUCTION OF NITRIC-OXIDE SYNTHASE BY INTERFERON-GAMMA IN MURINE MACROPHAGES [J].
CUNHA, FQ ;
MONCADA, S ;
LIEW, FY .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 182 (03) :1155-1159
[7]   INTERLEUKIN-10 (IL-10) INHIBITS HUMAN LYMPHOCYTE INTERFERON GAMMA-PRODUCTION BY SUPPRESSING NATURAL-KILLER-CELL STIMULATORY FACTOR/IL-12 SYNTHESIS IN ACCESSORY CELLS [J].
DANDREA, A ;
ASTEAMEZAGA, M ;
VALIANTE, NM ;
MA, XJ ;
KUBIN, M ;
TRINCHIERI, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (03) :1041-1048
[8]  
DASGUPTA A, 1987, INDIAN J MED RES, V85, P136
[9]  
DELPRETE G, 1993, J IMMUNOL, V150, P353
[10]   DIFFERENTIAL PROLIFERATIVE AND INTERLEUKIN-10 RESPONSES TO FRACTIONATED FILARIAL ANTIGENS - PREFERENTIAL RECOGNITION BY PATIENTS WITH CHRONIC LYMPHATIC DYSFUNCTION [J].
DIMOCK, KA ;
ADDISS, DG ;
EBERHARD, ML ;
LAMMIE, PJ .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (02) :403-412